Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Laboratories Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Monday, July 22, 2013 - 10:44am
tags:
earnings, Forest Labs
Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
Seeking Alpha
Monday, July 22, 2013 - 10:26am
tags:
HIV, Atripla, JNJ, Pfizer, GSK, Gilead, Dolutegravir, Edurant, China, TMC310911
It's showtime for Eli Lilly
Motley Fool
Monday, July 22, 2013 - 10:20am
tags:
earnings, Eli Lilly
Raptor receives positive orphan drug opinion from EU committee
Yahoo/Fly on the Wall
Monday, July 22, 2013 - 10:19am
tags:
Raptor Pharmaceuticals, Europe, procysbi
Bristol-Myers Squibb Earnings Up Next
Motley Fool
Monday, July 22, 2013 - 10:17am
tags:
earnings, Bristol-Myers Squibb
GSK CEO to discuss China scandal at quarterly results, Reuters reports
Yahoo/Fly on the Wall
Monday, July 22, 2013 - 10:17am
tags:
GSK, China, Andrew Witty
Glaxo says executives appear to have broken Chinese law
Yahoo/Reuters
Monday, July 22, 2013 - 10:16am
tags:
GSK, China
Bizarre Protection Against Alzheimer's: Cancer
Motley Fool
Sunday, July 21, 2013 - 11:39am
tags:
Eli Lilly, Merck
5 Drugmakers With a Lot on the Line Next Week
Motley Fool
Sunday, July 21, 2013 - 11:37am
tags:
Eli Lilly, InterMune, Gilead Sciences, Alexion, Biomarin
Amgen's Acquisition Ambition Leads Biotechs' Rise
Motley Fool
Sunday, July 21, 2013 - 11:36am
tags:
Amgen, M&A
TWi Pharma's reduced food effect metformin controlled release formulation gets US patent
Pharmabiz
Saturday, July 20, 2013 - 12:07pm
tags:
TWi Pharmaceuticals, diabetes, metformin
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, July 20, 2013 - 11:54am
tags:
Vivus, Cempra, Corcept Therapeutics
Wockhardt gets warning letter from USFDA over Waluj plant
Economic Times, India
Saturday, July 20, 2013 - 11:53am
tags:
Wockhardt
OncoMed: High Opening Day Returns For This Biotech Public Offering
Seeking Alpha
Saturday, July 20, 2013 - 11:52am
tags:
OncoMed
Can This Pharmaceutical Power Stay Healthy?
Daily Finance
Saturday, July 20, 2013 - 11:51am
tags:
JNJ
Can Merck Finally Get Past the Vioxx Scandal?
Wall Street Cheat Street
Saturday, July 20, 2013 - 11:27am
tags:
Merck, Vioxx, lawsuits
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Saturday, July 20, 2013 - 11:26am
tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, Bristol-Myers Squibb, Idenix
Alnylam Targets New Highs On Data Supporting RNAi
Seeking Alpha
Saturday, July 20, 2013 - 11:18am
tags:
RNA interference, Alnylam
Pacira Reports New Data
Yahoo/Zacks
Saturday, July 20, 2013 - 11:12am
tags:
Pacira, EXPAREL, pain management
Cytori Surges on Medistem Agreement
Yahoo/Zacks
Saturday, July 20, 2013 - 11:10am
tags:
Cytori, MediStem, stem cells

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.